
Eurazeo and IDI post positive figures for Q3
French listed PE players Eurazeo and IDI have seen an uptick in their NAV per share in the three months between June and September.
Eurazeo's NAV per share increased by 5.8% in the third quarter to €54.7 per share. The group's consolidated revenues also went up by 1.8%.
Meanwhile IDI enjoyed a more modest 2.39% increase in its NAV per share since June, up to €33.67 per share. The IDI group itself didn't record any investment or divestment in Q3 – its subsidiary Idinvest Partners invested €73.6m and cashed in €65.5m, though.
However, both Eurazeo and IDI still trade at a discount of around 34%.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater